I'm with you, but on reflection it does raise questions.
Mt. Peak or Speewah?
The acquisition of Speewah can be seen as positive, but one can also speculate that Tivan could have been in deep trouble with Mt. Peak. We don't have a permit for the Darwin plant, we have immensely increasing costs to build the mine, not to mention the logistics. Ore there, waste back, thousands of kilometres.It seems to me we're looking for a ride on the razor's edge with Speewah, maybe even the silk thread thing. I think Mt Peak will be put on hold for the time being, they will now push Speewah, purely for economic reasons, also because the transport would probably be more practicable and therefore cheaper.
Another question would be:
Why are they holding on to Darwin now?Last week the news that we are trying our luck again in Darwin. Surely the matter of KRR was examined here? If it is so difficult in the NT, why not look for something near Speewah if the regulations are supposed to be easier there?I now assume that it will be even more expensive than before. The quantities and recovery values of the possible samples are now decisive. It's a hot bet that promises a lot, but I don't think it will get any easier. We will have to continue to have staying power.
And there is a need for haste, because the awareness of certain things (green energy, vanadium for steel, armour and storage) is favourable, and we should take advantage of that. I am very curious to see what will become of TIVAN, I wish us all good luck.
- Forums
- ASX - By Stock
- Today’ announcement is phenomenal!
TVN
tivan limited
Add to My Watchlist
0.00%
!
9.2¢

I'm with you, but on reflection it does raise questions.Mt. Peak...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $190.2M |
Open | High | Low | Value | Volume |
9.2¢ | 9.2¢ | 9.2¢ | $7.9K | 85.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 71179 | 8.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.1¢ | 188094 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 71179 | 0.089 |
4 | 161948 | 0.088 |
3 | 157471 | 0.087 |
1 | 100000 | 0.086 |
4 | 30364 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.091 | 188094 | 1 |
0.092 | 50000 | 1 |
0.093 | 137827 | 1 |
0.094 | 276951 | 2 |
0.095 | 103812 | 4 |
Last trade - 10.00am 02/07/2025 (20 minute delay) ? |
Featured News
TVN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online